KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Inventory (2016 - 2026)

Medtronic's Change in Inventory history spans 13 years, with the latest figure at $131.0 million for Q1 2026.

  • For Q1 2026, Change in Inventory fell 34.5% year-over-year to $131.0 million; the TTM value through Jan 2026 reached $617.0 million, up 609.2%, while the annual FY2025 figure was $292.0 million, 110.07% up from the prior year.
  • Change in Inventory for Q1 2026 was $131.0 million at Medtronic, down from $299.0 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $410.0 million in Q3 2023 and bottomed at -$391.0 million in Q2 2024.
  • The 5-year median for Change in Inventory is $201.0 million (2022), against an average of $151.6 million.
  • The largest annual shift saw Change in Inventory surged 406.67% in 2022 before it crashed 13133.33% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $404.0 million in 2022, then plummeted by 49.01% to $206.0 million in 2023, then tumbled by 70.39% to $61.0 million in 2024, then surged by 390.16% to $299.0 million in 2025, then plummeted by 56.19% to $131.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Change in Inventory are $131.0 million (Q1 2026), $299.0 million (Q4 2025), and $373.0 million (Q3 2025).